Trastuzumab Recruiting Phase 2 Trials for Estrogen Receptor Negative / HER2/Neu Positive / Stage IV Breast Cancer / Progesterone Receptor Negative / Recurrent Breast Carcinoma / Triple-Negative Breast Carcinoma / Breast Carcinoma Metastatic in the Brain / HER2/Neu Negative Treatment
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02774681 | Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis |